Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Vaccine|January 1, 1993
Reduction of disulfide bonds in Plasmodium falciparum gp195 abolishes the production of growth-inhibitory antibodiesC P Locher, L Q TamBiochimica Et Biophysica Acta|December 28, 1992
Three matrix metalloproteinases form a non-covalent association with the rhoptry-associated protein-1 of Plasmodium falciparumC P Locher, F Vandekerckhove, L Q TamAIDS (London, England)|January 5, 2002
The nuclear factor kappa B and Spl binding sites do not appear to be involved in virus suppression by CD8 T lymphocytesC P Locher, S A Witt, J A LevyImmunology Letters|April 15, 1999
Suppression of human immunodeficiency virus type 1 replication by a soluble factor produced by CD8+ lymphocytes from HIV-2-infected baboonsC P Locher, D J Blackbourn, J A LevyJournal of Medical Primatology|January 10, 2003
Immune responses in baboons vaccinated with HIV-2 genetic expression librariesC P Locher, K F Sykes, D J Blackbourn, et al.The Journal of General Virology|December 1, 1996
CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cellsE Barker, K N Bossart, C P Locher, et al.Experimental Parasitology|October 1, 1996
Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitroC P Locher, L Q Tam, S P Chang, et al.Immunological Reviews|January 10, 2002
Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine developmentC P Locher, S A Witt, B G Herndier, et al.Virology|August 1, 1996
Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2UC2S W Barnett, H S Legg, Y Sun, et al.AIDS Research and Human Retroviruses|December 22, 1999
Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccinationC P Locher, R M Grant, E A Collisson, et al.Pageof 2